Researchers at UT Southwestern Medical Heart led a research revealed in JAMA Community Open which discovered that particular chemotherapies are related to an elevated long-term...
The FDA has accepted Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the primary and solely subcutaneous, chemo-free therapy for sufferers with EGFR-mutated non-small cell lung most...
Lively Biotech has obtained optimistic suggestions from regulators on a protocol modification to its ongoing proof-of-concept scientific trial evaluating tasquinimod in sufferers with myelofibrosis, a...
Kimberly Demirhan spoke with CURE about why it is vital for scientific trial enrollment to reflect actual world populations.It's crucial that scientific trials...
Ashley Dieks and Dr. Saad Z. Usmani mentioned how bicycling could assist sufferers address the emotional and bodily challenges of their myeloma prognosis.The...
Developments throughout the panorama of transplant medication have prompted updates in how medical doctors select donors for allogeneic hematopoietic cell transplants (also referred...
